AVAH stock

Is Aveanna Healthcare Holdings Inc (AVAH) overvalued? · P/E 149, rev $2.02B

Aveanna Healthcare Holdings Inc (AVAH) is a medical care facilities company listed on US.

This page asks whether Aveanna Healthcare Holdings Inc (AVAH) looks expensive on cached numbers — not a short thesis.

Latest reported AVAH revenue for 2024-12-28 was $2.02B. Net income was -$10.9M. Revenue was up 6.8% from 2023-12-30 to 2024-12-28. AVAH currently screens at market cap $920.0M and trailing P/E 148.7.

AVAH currently screens at market cap $920.0M and trailing P/E 148.7. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.

If the next AVAH 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.

Not investment advice. Use the AVAH stock page for the full model, not this heading.

Not investment advice.

Full AVAH analysis